- Country: USA
- Summary: Cell And Gene Therapy (Cgt) Access Model
- UST Ref No: 106389585
- Deadline: 28 Feb 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: USD 95500000
- Notice Type: Tender
- Document Ref. No.: CMS-2P2-25-001
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- This Notice Of Funding Opportunity (Nofo) Announces The Opportunity To Apply For Cooperative Agreement Funding To Support States Participation In The Cell And Gene Therapy (Cgt) Access Model (The Cgt Access Model Or The Model). Eligible Applicants Are States, The District Of Columbia, And Any U.S. Territory That Participates In The Medicaid Drug Rebate Program (Mdrp). A Maximum Of $9.55 Million May Be Awarded To Each Recipient, Depending On The Number Of States That Apply For Funding, Pending Availability Of Funds.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCell And Gene Therapy (Cgt) Access Model - USA Tender
The CENTERS FOR MEDICARE & MEDICAID SERVICES, a Government sector organization in USA, has announced a new tender for Cell And Gene Therapy (Cgt) Access Model. This tender is published on USARFP under UST Ref No: 106389585 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-02-28.
The estimated tender value is USD 95500000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
